| AMG 510 Ethnic Sensitivity Study (CodeBreaK 105). (NCT04380753) | Amgen | 2020-04-28 |
| A Study of the Absorption, Metabolism, and Excretion of [14C]-AMG 510 Following a Single Oral Dose in Healthy Male Subjects (NCT05578859) | Amgen | 2020-03-11 |
| Heart Failure Study to Evaluate Vital Signs and Overcome Low Use of Guideline-Directed Therapy by Remote Monitoring (NCT04292275) | Amgen | 2020-03-06 |
| A Study to Evaluate the Relative Bioavailability of AMG 510 Administered as Tablets and as a Water Dispersion in Healthy Participants (NCT05571163) | Amgen | 2020-03-06 |
| Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer (NCT04221542) | Amgen | 2020-03-04 |
| Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer (NCT03937154) | Amgen | 2020-02-26 |
| Talimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy (MASTERKEY-115) (Mk-3475-A07/KEYNOTE-A07). (NCT04068181) | Amgen | 2020-01-22 |
| Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic Cancers (NCT04117958) | Amgen | 2020-01-20 |
| Study to Evaluate the Drug-drug Interaction Effect of Omeprazole on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants (NCT05581992) | Amgen | 2020-01-06 |
| Safety and Tolerability of Inebilizumab, VIB4920, or the Combination in Highly Sensitized Candidates Awaiting Kidney Transplantation From a Deceased Donor (NCT04174677) | Amgen | 2019-12-27 |
| A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis (NCT04175613) | Amgen | 2019-12-20 |
| Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101) (NCT04185883) | Amgen | 2019-12-17 |
| Single and Multiple Ascending Dose Study of AMG 171 in Subjects With Obesity (NCT04199351) | Amgen | 2019-12-13 |
| A Study to Evaluate the Safety and Efficacy of VIB4920 in Participants With Rheumatoid Arthritis (NCT04163991) | Amgen | 2019-12-09 |
| A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome (NCT04129164) | Amgen | 2019-12-09 |
| The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS) (NCT04197453) | Amgen | 2019-12-06 |
| Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine (NCT03912337) | Amgen | 2019-12-04 |
| A Study to Evaluate the Drug-drug Interaction Effect of Itraconazole on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants (NCT05568082) | Amgen | 2019-12-03 |
| A Study to Assess the Effect of Food on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants (NCT05581758) | Amgen | 2019-11-14 |
| Study to Evaluate the Drug-drug Interactions Between Metformin and AMG 510 in Healthy Participants (NCT05550129) | Amgen | 2019-11-13 |
| A Study to Evaluate the Drug-drug Interaction Effect of Rifampin on the Pharmacokinetics of AMG 510 in Healthy Participants (NCT05577624) | Amgen | 2019-11-05 |
| Study to Evaluate the Effect of AMG 510 on the Pharmacokinetics (PK) of Digoxin in Healthy Participants (NCT05598281) | Amgen | 2019-11-05 |
| A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant (NCT04046549) | Amgen | 2019-10-30 |
| A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar Pustulosis (NCT04057937) | Amgen | 2019-10-16 |
| A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache (NCT03971071) | Amgen | 2019-10-07 |
| Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer (NCT03362177) | Amgen | 2019-09-30 |
| Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma (NCT03934684) | Amgen | 2019-09-16 |
| Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant (NCT04087720) | Amgen | 2019-09-09 |
| A Study to Evaluate the Safety, Tolerability Pharmacokinetics, and Pharmacodynamics of a New Spray Dried Dispersion (SDD) Formulation of CC-11050 After Single Dose of CC-11050 and to Evaluate the Pharmacokinetics of CC-11050 Under Fasted and Fed Conditions and After Coadministration With Omeprazole (NCT04139226) | Amgen | 2019-08-28 |
| A Study to Describe the Characteristics of Patients Treated With Apremilast for Plaque Psoriasis in Italian Routine Clinical Practice (NCT04031027) | Amgen | 2019-07-22 |
| Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine (NCT03836040) | Amgen | 2019-07-19 |
| A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical Therapy (NCT03930186) | Amgen | 2019-06-17 |
| Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout (NCT03994731) | Amgen | 2019-06-13 |
| Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke (NCT03872401) | Amgen | 2019-06-11 |
| Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients (NCT03927144) | Amgen | 2019-05-15 |
| Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia (NCT03433755) | Amgen | 2019-05-09 |
| A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (NCT03859427) | Amgen | 2019-05-08 |
| A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis (NCT03633708) | Amgen | 2019-04-29 |
| A Controlled Trial of Erenumab in Migraine Prevention (NCT03812224) | Amgen | 2019-04-12 |
| A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Adults With Manifestations of Plaque Psoriasis and Impaired Quality of Life (NCT03774875) | Amgen | 2019-03-28 |
| A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis (NCT03809663) | Amgen | 2019-03-15 |
| Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy (NCT03721172) | Amgen | 2019-03-11 |
| AMG 404 in Patients With Advanced Solid Tumors (NCT03853109) | Amgen | 2019-03-05 |
| An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis (NCT03777436) | Amgen | 2019-02-11 |
| A Study to Evaluate the Use of Apremilast in Patients With Psoriatic Arthritis, Naïve to Biological Treatment (NCT03828045) | Amgen | 2019-02-06 |
| A Study to Evaluate the Impact of Apremilast on Magnetic Resonance Imaging (MRI) Outcomes in Adults With Psoriatic Arthritis (NCT03783026) | Amgen | 2019-02-06 |
| Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC (NCT03792841) | Amgen | 2019-02-05 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of AMG 592 in Healthy Japanese Participants (NCT05885451) | Amgen | 2019-01-29 |
| A Study Evaluating the Efficacy and Safety of ABP 959 Compared With Eculizumab in Adult Participants With PNH (NCT03818607) | Amgen | 2019-01-22 |
| Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis. (NCT03747939) | Amgen | 2018-12-31 |
| Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) (NCT03852472) | Amgen | 2018-12-21 |
| Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis (NCT03701763) | Amgen | 2018-12-19 |
| A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis (NCT03817424) | Amgen | 2018-12-13 |
| Multiple Ascending Dose Study of AMG 598 in Adults With Obesity (NCT03757130) | Amgen | 2018-11-26 |
| Imaging of Coronary Plaques in Participants Treated With Evolocumab (NCT03570697) | Amgen | 2018-11-19 |
| An Interventional Study to Evaluate the Effect of Ivabradine on Exercise Capacity in Heart Transplant Recipients (NCT03619187) | Amgen | 2018-11-02 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 562 in Subjects With r/r Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, or Follicular Lymphoma (NCT03571828) | Amgen | 2018-10-29 |
| A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome (NCT03703908) | Amgen | 2018-10-01 |
| Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout (NCT03635957) | Amgen | 2018-09-26 |
| A Study to Assess Benefits of Apremilast in Patients With Moderate to Severe Chronic Plaque Psoriasis Followed by Dermatologists Under Real Life Settings in France (NCT03757013) | Amgen | 2018-09-25 |
| Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (NCT03541369) | Amgen | 2018-09-14 |
| A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC (NCT03392064) | Amgen | 2018-09-10 |
| A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100) (NCT03600883) | Amgen | 2018-08-27 |
| Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies (NCT03465540) | Amgen | 2018-08-17 |
| A Phase1 Study of VIB9600 (NCT03621605) | Amgen | 2018-08-14 |
| Safety and Tolerability of Repatha® (Evolocumab) in Indian Participants With Homozygous Familial Hypercholesterolemia (NCT03403374) | Amgen | 2018-08-04 |
| Study to Evaluate the Real-World Effectiveness, Safety and Tolerability of Treatment With Apremilast in Psoriatic Arthritis Patients Followed in Canadian Routine Care (APPRAISE) (NCT03608657) | Amgen | 2018-07-31 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AMG 890 in Subjects With Elevated Plasma Lipoprotein(a) (NCT03626662) | Amgen | 2018-07-30 |
| Open-label Extension of Study 20130173 of Denosumab in Children and Young Adults With Osteogenesis Imperfecta (NCT03638128) | Amgen | 2018-07-26 |
| A Study of Carfilzomib Plus Dexamethasone in Adults With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers (NCT03512353) | Amgen | 2018-07-05 |
| Study to Evaluate the Benefits for the Patient Associated With the Treatment of Plaque Psoriasis With Apremilast After Other Systemic Treatment in Conditions of Clinical Practice in Spain (NCT03539419) | Amgen | 2018-06-12 |
| Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT) (NCT03298412) | Amgen | 2018-05-23 |
| Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid Arthritis (NCT03410056) | Amgen | 2018-05-22 |
| A Study of CCX140-B in Subjects With FSGS (NCT03536754) | Amgen | 2018-05-17 |
| Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) (NCT03299244) | Amgen | 2018-05-15 |
| Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis (NCT03164928) | Amgen | 2018-05-07 |
| AMG 334 20160172 Pediatric Migraine PK Study. (NCT03499119) | Amgen | 2018-05-04 |
| Safety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host Disease (NCT03422627) | Amgen | 2018-04-27 |
| Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma (NCT03296696) | Amgen | 2018-04-18 |
| Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study (NCT03461211) | Amgen | 2018-04-16 |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus Erythematosus (NCT03451422) | Amgen | 2018-04-10 |
| Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases (NCT03256344) | Amgen | 2018-03-19 |
| Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL) (NCT03340766) | Amgen | 2018-03-16 |
| A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416 (NCT03283098) | Amgen | 2018-03-01 |
| Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders (UCDs) (NCT03335488) | Amgen | 2018-02-20 |
| A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis (NCT03432533) | Amgen | 2018-02-06 |
| Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma. (NCT03343847) | Amgen | 2018-01-27 |
| Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC) (NCT03319940) | Amgen | 2017-12-26 |
| Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 986 Administered Orally to Healthy Volunteers and Participants With Severely Impaired Renal Function (NCT03318809) | Amgen | 2017-12-12 |
| Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004 (NCT03301857) | Amgen | 2017-11-13 |
| A Study to Assess AMG 701 Montherapy, or in Combination With Pomalidomide, With or Without, Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (NCT03287908) | Amgen | 2017-11-13 |
| A Study of CCX168 in Japanese and Caucasian Healthy Adult Males (NCT05988008) | Amgen | 2017-10-23 |
| Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) (NCT03476239) | Amgen | 2017-10-18 |
| Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study (NCT03298867) | Amgen | 2017-10-04 |
| Controlled Trial Evaluating Avacopan in C3 Glomerulopathy (NCT03301467) | Amgen | 2017-09-29 |
| A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction. (NCT03456856) | Amgen | 2017-09-28 |
| A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (NCT02961881) | Amgen | 2017-09-18 |
| Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML) (NCT03224819) | Amgen | 2017-09-07 |
| Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention (NCT03238781) | Amgen | 2017-09-06 |
| Post-Marketing Surveillance Study of OTEZLA (NCT03284879) | Amgen | 2017-09-05 |